Avanir Pharmaceuticals products
NUEDEXTA (dextromethorphan/quinidine)
Indication: Treatment of pseudobulbar affect (PBA), characterized by involuntary laughing or crying episodes.
ONZETRA Xsail (sumatriptan powder intranasal)
Indication: Acute treatment of migraine; delivered via a breath-powered intranasal, dry powder system.
AVP-786 (deudextromethorphan/quinidine; deuterated)
Indication: Investigational therapy for agitation in Alzheimer’s dementia, among other neurologic or psychiatric disorders. Advanced in Phase III development.
No comments:
Post a Comment